Discover Thomson Reuters
Unilever on Wednesday effectively abandoned its plans to buy GlaxoSmithKline's consumer healthcare business, saying that it would not raise a 50 billion pound ($68 billion) offer that GSK previously rejected. Francis Maguire reports.
01:14
02:10
01:45
07:21
01:58
01:29
02:07
01:53
02:09
01:49
01:05
00:37
01:10
01:46
01:13
01:37
01:36
01:42
01:57